These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6540194)

  • 1. The use of human cancer cell lines as a primary screening system for antineoplastic compounds.
    Finlay GJ; Baguley BC
    Eur J Cancer Clin Oncol; 1984 Jul; 20(7):947-54. PubMed ID: 6540194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cellular basis of drug sensitivity of human colon, pancreatic, and renal carcinoma cell lines with that of leukemia cell lines.
    Ozawa S; Yasuda T; Inaba M
    Cancer Chemother Pharmacol; 1988; 22(1):41-6. PubMed ID: 3165059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of in vivo and in vitro drug sensitivities of Lewis lung carcinoma and P388 leukaemia to analogues of amsacrine.
    Baguley BC; Wilson WR
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):607-13. PubMed ID: 3653185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of in vitro activity of cytotoxic drugs towards human carcinoma and leukaemia cell lines.
    Finlay GJ; Wilson WR; Baguley BC
    Eur J Cancer Clin Oncol; 1986 Jun; 22(6):655-62. PubMed ID: 3755682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a cisplatin-resistant human ovarian carcinoma cell line expressing cross-resistance to 5-fluorouracil but collateral sensitivity to methotrexate.
    Hill BT; Shellard SA; Hosking LK; Dempke WC; Fichtinger-Schepman AM; Tone T; Scanlon KJ; Whelan RD
    Cancer Res; 1992 Jun; 52(11):3110-8. PubMed ID: 1591724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines.
    Avramis IA; Laug WE; Sausville EA; Avramis VI
    Cancer Chemother Pharmacol; 2003 Oct; 52(4):307-18. PubMed ID: 12827297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synchronization of cells in the S phase of the cell cycle by 3'-azido-3'-deoxythymidine: implications for cell cytotoxicity.
    Chandrasekaran B; Kute TE; Duch DS
    Cancer Chemother Pharmacol; 1995; 35(6):489-95. PubMed ID: 7882457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines.
    Chu E; Drake JC; Koeller DM; Zinn S; Jamis-Dow CA; Yeh GC; Allegra CJ
    Mol Pharmacol; 1991 Feb; 39(2):136-43. PubMed ID: 1704999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic activity of calcein acetoxymethyl ester (Calcein/AM) on primary cultures of human haematological and solid tumours.
    Jonsson B; Liminga G; Csoka K; Fridborg H; Dhar S; Nygren P; Larsson R
    Eur J Cancer; 1996 May; 32A(5):883-7. PubMed ID: 9081371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Consolidation therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of cytosine arabinoside, epipodophyllotoxins and cyclophosphamide.
    Estlin EJ; Yule SM; Lowis SP
    Cancer Treat Rev; 2001 Dec; 27(6):339-50. PubMed ID: 11908927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basis of observed resistance of L1210 leukemia in mice: methotrexate, 6-thioguanine, 6-methylmercaptopurine riboside, 6-mercaptopurine, 5-fluorouracil, and 1-beta-D-arabinofuranosylcytosine administered in different combinations.
    Kim K; Blechman WJ; Riddle VG; Pardee AB
    Cancer Res; 1981 Nov; 41(11 Pt 1):4529-34. PubMed ID: 7198006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New screening system for selection of anticancer drugs for treatment of human colorectal cancer.
    Scheithauer W; Clark GM; Moyer MP; Von Hoff DD
    Cancer Res; 1986 Jun; 46(6):2703-8. PubMed ID: 3698003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of newly established colorectal cell lines to cytotoxic drugs and monoclonal antibody drug conjugates.
    Durrant LG; Garnett MC; Gallego J; Armitage NC; Ballantyne KC; Marksman RA; Hardcastle JD; Baldwin RW
    Br J Cancer; 1987 Dec; 56(6):722-6. PubMed ID: 3435698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced experimental metastatic capacity of a murine melanoma following pre-treatment with anticancer drugs.
    McMillan TJ; Hart IR
    Clin Exp Metastasis; 1986; 4(4):285-92. PubMed ID: 2431822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of variation in inherent sensitivities to radiation, 5-fluorouracil and methotrexate in a series of human and murine tumor cell lines in vitro.
    Bellamy AS; Whelan RD; Hill BT
    Int J Radiat Oncol Biol Phys; 1984 Jan; 10(1):87-93. PubMed ID: 6698828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective uptake of toxic nucleoside (125IUdR) by resistant cancer.
    Bagshawe KD; Sharma K; Southall PJ; Boden JA; Boxer GM; Patridge TA; Antoniw P; Pedley RB
    Br J Radiol; 1991 Jan; 64(757):37-44. PubMed ID: 1998836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines.
    Johnston PG; Drake JC; Trepel J; Allegra CJ
    Cancer Res; 1992 Aug; 52(16):4306-12. PubMed ID: 1643628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multidrug sensitivity phenotype of human lung cancer cells associated with topoisomerase II expression.
    Giaccone G; Gazdar AF; Beck H; Zunino F; Capranico G
    Cancer Res; 1992 Apr; 52(7):1666-74. PubMed ID: 1312895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential chemotherapeutic susceptibility of human T-lymphocytes and B-lymphocytes in culture.
    Ohnuma T; Arkin H; Minowada J; Holland JF
    J Natl Cancer Inst; 1978 Apr; 60(4):749-52. PubMed ID: 305485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential of continuous tumour cell lines for establishing patterns of cross-resistance and collateral sensitivity in vitro.
    Hill BT
    Drugs Exp Clin Res; 1986; 12(1-3):293-8. PubMed ID: 3732052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.